International Drug & Explosives Detection Firm IDenta Corp. Reports on Progress in Germany

Jan 26, 2010, 10:00 ET from IDenta Corp.

JERUSALEM, Jan. 26 /PRNewswire-FirstCall/ -- Israel, IDenta Corp. (PINK SHEETS: IDTA), CEO Yaacov Shoham today released this statement concerning developments in Germany.

Mr. Shoham stated, "IDenta has received yesterday a very important and prestigious order from Germany through IDenta's local representative, PMC company from Cologne, to supply IDenta Alert explosive identifiers."

The IDenta Alert kits will be used at the 11 major international airports in Germany, to identify suspected substances.

The order is from the German Federal Police and the kits will be used also by the GSG9 (counter-terrorism and special operations unit of the German Federal Police).

As was already stated in IDenta's press release from December 9, 2009, IDenta Corp is making substantial progresses in the different German Homeland Security market with the different products.

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

Information concerning IDenta's entire product line may be found at www.IDenta.biz

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.identa.biz.

For information about the Accutest® - IDenta products in the US, please contact: Mr. Eyal Golan, Manager, Business Development, JANT PHARMACAL CORPORATION, 16255 Ventura Blvd. #505, Encino, CA 91436, Toll Free: 800-676-5565, 661-478-0582 (mobile), golan@accutest.net, www.accutestidenta.net.

Contact:

Yaacov Shoham

IDenta Corp.

CEO

Tel: +972-52-6554487

fpi@drugsdetector.com

http://www.identa.biz


SOURCE IDenta Corp.



RELATED LINKS

http://www.IDenta.biz